These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 6257825)
1. Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus. Cartwright B; Chapman WG; Brown F J Gen Virol; 1980 Oct; 50(2):369-75. PubMed ID: 6257825 [TBL] [Abstract][Full Text] [Related]
2. Antibody response to 146S particle, 12S protein subunit and isolated VP1 polypeptide of foot-and-mouth disease virus type Asia-1. Rao MG; Butchaiah G; Sen AK Vet Microbiol; 1994 Mar; 39(1-2):135-43. PubMed ID: 8203119 [TBL] [Abstract][Full Text] [Related]
3. Nature of the antibody response to the foot-and-mouth disease virus particle, its 12S protein subunit and the isolated immunizing polypeptide VP1. Cartwright B; Morrell DJ; Brown F J Gen Virol; 1982 Dec; 63(2):375-81. PubMed ID: 6296284 [TBL] [Abstract][Full Text] [Related]
4. Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Cartwright B; Chapman WG; Sharpe RT Res Vet Sci; 1982 May; 32(3):338-42. PubMed ID: 6179141 [TBL] [Abstract][Full Text] [Related]
5. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit. Hardy MM; Moore DM J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797 [TBL] [Abstract][Full Text] [Related]
6. Detection and typing of foot-and-mouth disease virus by enzyme-linked immunosorbent assay: a sensitive, rapid and reliable technique for primary diagnosis. Roeder PL; Le Blanc Smith PM Res Vet Sci; 1987 Sep; 43(2):225-32. PubMed ID: 2825310 [TBL] [Abstract][Full Text] [Related]
7. Effect of thiomersal on dissociation of intact (146S) foot-and-mouth disease virions into 12S particles as assessed by novel ELISAs specific for either 146S or 12S particles. Harmsen MM; Fijten HP; Westra DF; Coco-Martin JM Vaccine; 2011 Mar; 29(15):2682-90. PubMed ID: 21316500 [TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of monoclonal antibodies to foot-and-mouth disease virus type Asia-1. Amineva SP; Davydova NL; Mamatkulova LU; Globenko LA; Mishchenko VA Biochemistry (Mosc); 1997 May; 62(5):469-73. PubMed ID: 9275286 [TBL] [Abstract][Full Text] [Related]
9. Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus. Doel TR; Chong WK Arch Virol; 1982; 73(2):185-91. PubMed ID: 6293410 [No Abstract] [Full Text] [Related]
10. Antigenic comparison of different foot-and-mouth disease virus types using monoclonal antibodies defining multiple neutralizing epitopes on FMDV A5 subtypes. Saiz JC; Gonzalez MJ; Morgan DO; Card JL; Sobrino F; Moore DM Virus Res; 1989 May; 13(1):45-60. PubMed ID: 2473578 [TBL] [Abstract][Full Text] [Related]
11. Neutralizing antibodies to all seven serotypes of foot-and-mouth disease virus elicited by synthetic peptides. Francis MJ; Hastings GZ; Clarke BE; Brown AL; Beddell CR; Rowlands DJ; Brown F Immunology; 1990 Feb; 69(2):171-6. PubMed ID: 2155177 [TBL] [Abstract][Full Text] [Related]
12. Foot-and-mouth disease virus antigenic landscape and reduced immunogenicity elucidated in atomic detail. Li H; Liu P; Dong H; Dekker A; Harmsen MM; Guo H; Wang X; Sun S Nat Commun; 2024 Oct; 15(1):8774. PubMed ID: 39389971 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles. McCullough KC; Butcher R Arch Virol; 1982; 74(1):1-9. PubMed ID: 6186225 [TBL] [Abstract][Full Text] [Related]
14. The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine. Mansilla FC; Turco CS; Miraglia MC; Bessone FA; Franco R; Pérez-Filgueira M; Sala JM; Capozzo AV PLoS One; 2020; 15(5):e0232782. PubMed ID: 32369529 [TBL] [Abstract][Full Text] [Related]
15. The main antigenic determinant detected by neutralizing monoclonal antibodies on the intact foot-and-mouth disease virus particle is absent from isolated VPI. Meloen RH; Briaire J; Woortmeyer RJ; van Zaane D J Gen Virol; 1983 May; 64(Pt 5):1193-8. PubMed ID: 6188800 [TBL] [Abstract][Full Text] [Related]
16. Mapping of foot-and-mouth disease virus antigenic sites recognized by single-domain antibodies reveals different 146S particle specific sites and particle flexibility. Harmsen MM; Li H; Sun S; van der Poel WHM; Dekker A Front Vet Sci; 2022; 9():1040802. PubMed ID: 36699337 [TBL] [Abstract][Full Text] [Related]
17. Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies. Stave JW; Card JL; Morgan DO J Gen Virol; 1986 Oct; 67 ( Pt 10)():2083-92. PubMed ID: 2428926 [TBL] [Abstract][Full Text] [Related]
18. Induction of neutralizing antibodies and immunity in vaccinated guinea pigs by cyanogen bromide-peptides of VP3 of foot-and-mouth disease virus. Kaaden OR; Adam KH; Strohmeier K J Gen Virol; 1977 Feb; 34(2):397-400. PubMed ID: 65445 [TBL] [Abstract][Full Text] [Related]
19. Isolation of Single-Domain Antibody Fragments That Preferentially Detect Intact (146S) Particles of Foot-and-Mouth Disease Virus for Use in Vaccine Quality Control. Harmsen MM; Seago J; Perez E; Charleston B; Eblé PL; Dekker A Front Immunol; 2017; 8():960. PubMed ID: 28861080 [TBL] [Abstract][Full Text] [Related]
20. [Correlation between 146S antigen dosage and antibody titers after foot-and-mouth disease vaccination in cattle and swine]. Liebermann HT; Thalmann G; Nöckler A; Felfe P Arch Exp Veterinarmed; 1988 Jul; 42(4):528-36. PubMed ID: 2847677 [No Abstract] [Full Text] [Related] [Next] [New Search]